In Australia, little prevalence data around vision impairment exist. However, self‐reported data from the Australian Bureau of Statistics 2017–18 National Health Survey1 suggest that around 800 000 people have a vision impairment or are blind (excluding uncorrected refractive errors).2 The leading cause of vision impairment in working‐age adults are inherited retinal diseases (IRDs)3 — a group of genetic conditions that primarily affect the retina. Other than one particular gene therapy for biallelic RPE65‐associated retinal dystrophy, there are no other clinically available treatments to safely prevent vision loss or restore vision for someone with an IRD.4
With no universally accepted definition of vision impairment,5 we use “vision impairment” in this article to refer to a significant reduction in vision that causes individuals to rely on visual substitution skills for daily living.6 Understanding the perspectives of individuals who have a vision impairment is necessary to develop meaningful interventions, policies and practices. However, too often these individuals have limited access to research opportunities and health information due to the inaccessibility of information.7,8,9 Resources, such as the Web content accessibility guidelines, provide useful guidance for how to make digital information more accessible.10,11 However, a lack of awareness and integration of these guidelines across national policy and professional code results in little uptake. Challenges around feasibility and capacity also arise for researchers and clinicians when embedding such practices.
Sharing our experiences
In 2023–2024, we undertook a James Lind Alliance Priority Setting Partnership (PSP) to identify the top research priorities for IRDs in Australia, from the perspectives of individuals with lived experience and health professionals.12,13 As a first step of the PSP, we established a 14‐member steering group consisting of people with lived experience (individuals with an IRD or other vision impairment, and caregivers), community organisations representatives, health professionals (clinical geneticists, ophthalmologists, speech pathologist, optometrist), and researchers. The steering group met ten times over 18 months to guide the PSP, which included two national surveys and online workshops with the IRD community.12
Here, we share our learnings from undertaking the PSP surveys and hosting an in‐person educational event for the IRD community. This article has been co‐written with our PSP steering group, including seven co‐authors who have lived experience of vision impairment. By providing these co‐developed recommendations, summarised in the Box, our aim is to provide feasible strategies for researchers and clinicians to undertake more accessible research and better facilitate information access for individuals with a vision impairment.
Build meaningful connections with individuals who have lived experience
Our steering group was integral to ensuring an inclusive study design and casting a wide enough recruitment net to ensure diversity of respondents. They supported recruitment through leveraging of personal networks and connections with over 20 community‐based organisations who also promoted our PSP surveys via mechanisms such as social media posts and member newsletters. We invited organisations to partner given their experience communicating with their specific communities, direct access to our target audience and established status as trusted sources of information. We provided suggested content and social media tiles to reduce the burden on these often limited‐staffed organisations who provided in‐kind support.
Shift the focus to people‐first language and a social model of disability
Our research practices veered away from the medical model of disability toward a social model, ensuring that individuals with lived experience were equal partners with the researchers. At study outset, we acknowledged the researchers’ responsibility in making necessary accommodations to support their meaningful participation.
Although differences exist within and between communities,14 the use of people‐first language (ie, highlighting the individual person first, rather than their disability) was mentioned several times by our steering group as their preference. For our PSP and event, we used people‐first language. However, this was an experiential learning curve, with resources requiring updates as we gained further insights from the community, and with the ongoing debate around appropriate language within the broader disability sector. We also minimised the use of the term “patient” to only denote a person who was receiving medical care, rather than as a collective term to refer to people living with an IRD. Following good practice, we remained flexible by continuing to ask for preferences and to mirror the language of individuals with lived experience.15
Implement strategies to ensure all individuals can fully participate
Before the first steering group meeting, we invited members to share any needs or preferences to be able to fully participate in meetings. This resulted in numerous accommodations, such as members announcing their name before speaking. Allocated meeting times also took into consideration that written content shared on screen would be read out loud.
In preparing our event, we prioritised the importance of lighting, physical navigation space, audio induction loops, and location. We invited attendees to share any accessibility requirements when registering, and communicated about the space to attendees ahead of time. When opening the event, our Master of Ceremonies (a person who has a vision impairment) also provided descriptive directions of the space. For our lived experience panel, the Panel Chair (a person who has a vision impairment) directed questions to specific individuals in the order of their seated position, which ensured conversation flow without the use of non‐verbal, turn‐taking cues.
Move away from the default methods of information provision
Videos and infographics are effective tools for sharing health information. However, relying solely on these formats can discriminate against individuals with vision impairment. For our PSP, we developed a short animation that also verbally explained the study. Following feedback from partners about our first PSP survey around eligibility, we also developed a video about what IRDs are. Developing this in Auslan as the primary language (to support a proportion of the IRD community who are deafblind), complemented with spoken English and a transcription, made it more accessible without detriment to sighted and hearing populations.16
For our PSP and event, we developed materials following accessibility recommendations from Vision Australia17 and VisAbility,18 and included QR codes for online access if provided in hard copy. All materials could be accessed via screen readers and could be magnified. We underwent multiple reviews of formatting and punctuation, especially full stops, which is crucial for people using screen readers. See the Supplementary Information for our co‐developed Word template.
We provided our event presenters with guidelines and PowerPoint templates. Presenters were advised to minimise the use of PowerPoint presentations and to provide verbal descriptions of any necessary visuals.
Adapt data collection methods
For our PSP surveys, we used the online survey platform Qualtrics (www.qualtrics.com/en‐au) as our primary data collection method because it was deemed by our steering group as compatible with most screen readers. We undertook numerous rounds of user testing with individuals of different ages and levels of comfort with technology. We also provided the opportunity for participation on paper (including in Braille), phone call (with the option for a language interpreter), or video teleconference in Auslan. Participation in the more than 220 survey responses received was predominantly in written English via Qualtrics or paper. As such, we recommend that alternative approaches to data collection be scoped and budgeted should they be requested, rather than investing significant efforts at project outset.
Conclusion
Accessibility is an ongoing commitment that will continue to change based on the needs and experiences of the community. Here, we share our current recommendations for more equitable access to research and clinical information for individuals who have a vision impairment. We strongly suggest that researchers and clinicians weigh up the potential value and impact of incorporating these recommendations with the social and ethical cost of forgoing them.
Box – Recommendations to improve information access for people who have a vision impairment
|
|||||||||||||||
Build meaningful connections with individuals who have lived experience and community organisations |
|||||||||||||||
|
|||||||||||||||
Shift the focus to people‐first language and a social model of disability |
|||||||||||||||
|
|||||||||||||||
Implement strategies to ensure all individuals can fully participate |
|||||||||||||||
|
|||||||||||||||
Move away from the default methods of information provision |
|||||||||||||||
|
|||||||||||||||
Adapt data collection methods |
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
Provenance: Not commissioned; externally peer reviewed.
Open access:
Open access publishing facilitated by University of New South Wales, as part of the Wiley – University of New South Wales agreement via the Council of Australian University Librarians.
Eden Robertson and Anai Gonzalez‐Cordero are supported by a 2021 Medical Research Future Fund Stem Cell Therapies Mission (APP2016039). Consumers (Meredith Prain, Leighton Boyd, Emily Shepard, Hollie Feller, Sally Karandrews, and Kanae Yamamoto) are also supported by a 2021 Medical Research Future Fund Stem Cell Therapies Mission (APP2016039). Kate Hetherington is supported by the Cancer Institute Translational Program Grant (2021/TPG2112) as well as Luminesce Alliance and the Zero Childhood Cancer National Personalised Medicine Program for children with high risk cancer, a joint initiative of Children's Cancer Institute and Kids Cancer Centre, Sydney Children's Hospital, Randwick.
No relevant disclosures.